Genomed (WAR:GEN) Construction In Progress: zł0.02 Mil (As of Mar. 2026)


WAR:GEN Genomed SA WAR:GEN
78 GF Score
Price zł25.80
GF Value zł37.76
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Genomed Construction In Progress?

Genomed WAR:GEN 78 Construction In Progress is zł0.02 Mil as of Mar. 2026. GuruFocus rates WAR:GEN with a GF Score™ of 78/100 and a GF Value™ of zł37.76 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Genomed's quarterly construction in progress declined from Sep. 2025 (zł0.06 Mil) to Dec. 2025 (zł0.02 Mil) but then stayed the same from Dec. 2025 (zł0.02 Mil) to Mar. 2026 (zł0.02 Mil).

Genomed's annual construction in progress stayed the same from Dec. 2023 (zł0.02 Mil) to Dec. 2024 (zł0.02 Mil) and stayed the same from Dec. 2024 (zł0.02 Mil) to Dec. 2025 (zł0.02 Mil).

Genomed Construction In Progress Historical Data

* Premium members only.

The historical data trend for Genomed's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genomed Construction In Progress Chart

Genomed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.34 0.11 0.02 0.02 0.02

Genomed Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.06 0.02 0.02
WAR:GEN
78GF Score
Genomed SA WAR:GEN
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genomed Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of zł0.02 Mil mean?
Genomed (WAR:GEN) has a Construction In Progress of zł0.02 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Genomed and its competitors.
Is Genomed's Construction In Progress too high?
Genomed's current Construction In Progress is zł0.02 Mil. Overall, Genomed has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Genomed's Construction In Progress compare to TMO and DHR?
Genomed's Construction In Progress of zł0.02 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Medical Diagnostics & Research company?
A good Construction In Progress depends on the Medical Diagnostics & Research industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Genomed and its competitors. Genomed's current Construction In Progress is zł0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genomed stock overvalued right now?
Based on GuruFocus' analysis, Genomed (WAR:GEN) is currently considered Significantly Undervalued. The stock's GF Value™ is zł37.76, compared to a current price of zł25.80 — trading 31.7% below its estimated fair value. The current Construction In Progress is zł0.02 Mil. Genomed's overall GF Score™ is 78/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Genomed (WAR:GEN), the current Construction In Progress is zł0.02 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Genomed (WAR:GEN) Overvalued in 2026?

Based on GuruFocus' analysis, Genomed stock appears to be undervalued. The current stock price of zł25.80 is trading 31.7% below its estimated GF Value™ of zł37.76. GuruFocus considers Genomed to be Significantly Undervalued.

Key valuation signals for WAR:GEN:

  • Construction In Progress: zł0.02 Mil
  • GF Value™: zł37.76 vs. price of zł25.80 (31.7% below fair value)
  • GF Score™: 78/100 with 2 warning signs

No single metric tells the full story. See the WAR:GEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genomed Business Description

Address Ulica Ponczowa 12, Warszawa, POL, 02-971
Genomed SA assembles outstanding molecular biologists and genetic diagnosticians. The company provides diagnostic service that comprises DNA analysis and congenital diseases diagnostics based on DNA sequencing. It offers Diagnostic service and Service for scientific purposes.
78GF Score

Get the complete analysis for WAR:GEN

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł25.80
Price
zł37.76
GF Value